Home › Tokyo Institute Of Technology And Astellas Launch Collaborative Research For New Anti-Dengue Virus Drugs For Neglected Tropical Diseases
 

Keywords :   


Tokyo Institute Of Technology And Astellas Launch Collaborative Research For New Anti-Dengue Virus Drugs For Neglected Tropical Diseases

2013-03-21 04:09:00| drugdiscoveryonline News Articles

Tokyo Institute of Technology ("Tokyo Tech"; Tokyo, Japan; President: Yoshinao Mishima) and Astellas Pharma Inc. ("Astellas")(TOKYO:4503)(President and CEO: Yoshihiko Hatanaka) recently announced that they have signed a joint research agreement for drug discovery research utilizing Tokyo Tech's TSUBAME2.0 supercomputer to efficiently discover candidates for the treatment of neglected tropical diseases ("NTDs") caused by dengue virus

Tags: research technology institute drugs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Digital video subscriptions to reach 3.5 billion by 2028
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
More »